查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198671

超低溫冰箱市場 - 增長、趨勢、COVID-19 影響和預測2023-2028

Ultra Low Temperature Freezers Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

超低溫冰箱市場預計在預測期內（2022-2027 年）以 3.9% 的複合年增長率增長。

COVID-19 對市場增長的影響是巨大的，因為超低溫冰箱在儲存和分發需要超低溫的大量 COVID-19 疫苗方面發揮了關鍵作用。 根據世界衛生組織的數據，2021 年 9 月，超低溫冰箱將疫苗儲存容量增加到 900 萬支。 低溫鏈容量的增加使 COVAX（獲取 COVID-19 工具 (ACT) 加速器的疫苗支柱）能夠運送輝瑞公司從美國捐贈的 250 萬劑疫苗。 此外，在大流行期間增加超低溫冷水機的戰略發展和產品發布也推動了市場增長。 例如，2021 年 1 月，Telstar 的 Boreas 超低溫冰箱設計用於在 -86度C 下儲存 COVID-19 疫苗。 該冷凍櫃採用真空板高度隔熱，即使環境溫度為+28度C，也能保持-80度C的溫度。 因此，COVID-19 對市場增長產生了重大影響。

此外，由於傳染病和癌症等慢性疾病的增加，新藥的發現和開發正在取得進展，並刺激了對超低溫冰箱（ULTF）的需求。 研發和生物樣本庫對超低溫冰箱的需求特別高，用於存儲和運輸藥物、□、化學品、病毒、細菌、細胞製劑和組織樣本。

此外，2021年6月，Thermo Fisher Scientific將推出TSX系列超低溫（ULT），用於疫苗、細胞培養物、生物製劑和試劑等材料的可持續環保。底部。 此外，2021 年 12 月，BioLife Solutions 與聯合國兒童基金會簽訂了一項合作協議，以在非洲、中東和南美洲的發展中社區擴展對溫度敏感的 COVID-19 疫苗的熱穩定性。作為該計劃的一部分，聯合國兒童基金會已按國家/地區批准了 Sterling 的 SU780XLE 立式冷凍機和世界上第一款便攜式冷凍機 UL25NEU 型號。

在這種背景下，市場有望在預測期內呈現增長。 然而，與超低溫冷凍機相關的高成本和關於超低溫冷凍機的嚴格監管問題可能會阻礙市場增長。

超低溫冰箱市場趨勢

直立式超低溫冰箱細分市場有望佔據主要市場份額

直立式超低溫冰箱隨時可用，打開後快速冷卻，取用方便，內部隔間可單獨定制。 但是，不經常使用的物品可以安全地長期存放在臥式超低溫冰箱中，因此可以將臥式超低溫冰箱用於特定用途。 立式超低溫冷凍機（ULT冷凍機）通常用於儲存藥物、□、化學品、病毒、細菌、細胞製劑、組織樣本等，溫度範圍為-40度C至-86度C。 立式 ULT 提供的這些優勢有望在不久的將來加速這些冷凍機的採用。

此外，藥物和疫苗研發活動的激增推動了該行業的增長。 在接下來的幾年裡，我們預計會看到一些藥物在臨床試驗中的推出，這些藥物需要低溫條件來儲存和運輸原材料。 根據國際製藥商協會聯合會 (IFPMA) 的數據，2021 年有 2,178 項處於 III 期試驗，2020 年有 3,752 項。 因此，預計在預測期內立式超低溫冰箱領域的需求將增長。

因此，上述所有因素都有望增加對立式超低溫冰箱的需求，從而推動該細分市場的增長。

北美將佔據很大的市場份額，預計在預測期內也會如此

由於多家生物樣本庫、製藥公司和生物技術公司的存在，預計北美將在全球超低溫冰箱市場佔據重要的市場份額。 據估計，該地區在全球超低溫冷凍機市場中佔有相當大的份額，並且這一趨勢預計將在預測期內繼續。

此外，由於 COVID-19 疫苗的研發活動增加，預計 COVID-19 的爆發將在預測期內推動該地區的超低溫冰箱市場。 例如，BINDER CO2 冰箱可幫助科學家在研究期間保存冠狀病毒樣本。

此外，技術先進的超低溫冰箱的高采用率和產品發布預計將推動整個地區的市場增長。 例如，2020 年 5 月，Thermo Fisher Scientific 推出了一項新服務，從其關聯的 TSX 系列超低溫冰箱收集和跟蹤關鍵性能數據，以確保樣品和產品的安全。 Thermo Scientific 的智能連接系統功能允許您記錄 37 個警報和 26 個運行指標，以一起徹底驗證您的 TSX 系列超低溫冰箱。

因此，上述所有因素預計將增加對超低溫冰箱的需求，並在預測期內推動市場增長。

超低溫冷凍機市場競爭者分析

所研究的市場競爭適中，有幾家公司在該市場開展業務。 市場上的主要參與者包括 Thermo Fisher Scientific, Inc、PHC Holdings Corporation、Haier Biomedical、Arctiko A/S、Helmer Scientific、Eppendorf AG、Abzil Telstar S.L、Labcold Ltd、Bionics Scientific Technologies (P) Ltd 和 Global Cooling，公司

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 在生物樣本庫、藥物發現和生命科學研究領域的應用擴展
    • 超低溫冰箱的技術進步
  • 市場製約因素
    • 與超低溫冰箱相關的高成本
    • 關於超低溫冰箱的嚴格監管問題
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品類型
    • 立式超低溫冰箱
    • 臥式超低溫冰箱
  • 最終用戶
    • 生物樣本庫
    • 製藥公司、生物技術公司
    • 學術和研究機構
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Thermo Fisher Scientific, Inc
    • PHC Holdings Corporation
    • Haier Biomedical
    • Arctiko A/S
    • Helmer Scientific
    • Eppendorf AG
    • Abzil Telstar S.L
    • Labcold Ltd
    • Bionics Scientific Technologies（P）Ltd
    • Global Cooling, Inc

第7章 市場機會今後動向

簡介目錄
Product Code: 67649

The Ultra-Low Temperature Freezers Market is expected to witness a CAGR of 3.9% during the forecast period (2022-2027).

The impact of COVID-19 on the market's growth was substantial as ultra-low temperature freezers played a crucial role in the storage and distribution of large amounts of COVID-19 vaccinations that required ultra-cold conditions. According to the World Health Organization data, in September 2021, vaccine storage capacity increased to nine million due to ultra-low temperature freezers. This increased ultra-cold chain capacity allowed COVAX, the vaccine pillar of the Access to COVID-19 Tools (ACT) Accelerator, to ship 2.5 million Pfizer-donated doses from the United States. Moreover, growing strategic developments and product launches with respect to ultra-low temperature freezers amid the pandemic have boosted the market's growth. For instance, in January 2021, Telstar's Boreas ultra-low-temperature freezers were designed to store COVID-19 vaccinations at -86°C. The freezers have vacuum panels for high degrees of insulation, allowing them to maintain a temperature of -80°C with ambient temperatures as high as +28°C. Thus, COVID-19 has had a significant impact on the growth of the market.

Moreover, rising infectious diseases, cancer, and other chronic diseases have led to new drug discoveries and development, stimulating demand for ultra-low temperature freezers (ULTF). Demand for ultra-low temperature freezers is particularly high in research and development and in biobanks for storing and transporting drugs, enzymes, chemicals, viruses, bacteria, cell preparations, and tissue samples.

Additionally, in June 2021, Thermo Fisher Scientific launched the TSX Series Ultra-Low Temperature (ULT) to deliver environmentally sustainable protection of materials such as vaccines, cell culture media, biologics, and reagents. Furthermore, in December 2021, BioLife Solutions, Inc. signed a partnership agreement with UNICEF to extend the thermal stability of temperature-sensitive COVID-19 vaccines in developing communities in Africa, the Middle East, and South America. As part of this program, UNICEF has approved Stirling's upright SU780XLE freezers and first-of-its-kind, portable UL25NEU freezer models for country-specific selection.

Thus, owing to the abovementioned factors, the market is expected to show growth over the forecast period. However, high costs associated with ultra-low temperature freezers and stringent regulatory issues regarding ultra-low temperature freezers may hinder the growth of the market.

Ultra Low Temperature Freezers Market Trends

Upright Ultra-Low Temperature Freezers Segment is Expected to Hold a Major Market Share

The upright ULT freezer enables quick cooling after opening, simple access, and individually customizable inner compartments for regular usage. However, less used items can be stored in a chest ULT freezer safely for an extended period of time that allows the usage of the chest ULT for specific purposes. Upright ultra-low temperature freezers (ULT freezers) typically have a temperature range of -40°C to -86°C and are used to store drugs, enzymes, chemicals, viruses, bacteria, cell preparations, and tissue samples. Such advantages offered by upright ULTs are anticipated to boost the adoption of these freezers in the near future.

Moreover, the segment's growth is driven by a surge in research and development activities for pharmaceutical drugs and vaccines. Several medicines under clinical trial are expected to be launched over the coming years that may require ultra-cold conditions for storage and transportation of raw materials. According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in 2021, 2,178 are in Phase III trials, and 3,752 are in Phase II trials in 2020. Thus, the demand for the upright ultra-low temperature freezer segment is expected to grow over the forecast period.

Thus, all the above factors are expected to increase demand for upright ultra-low temperature freezers, thereby boosting the segment's growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

North America is expected to hold a significant market share in the global ultra-low temperature freezers market due to the presence of several biobanks, pharmaceutical and biotechnology companies within the region. The region is estimated to hold a substantial share of the global ultra-low temperature freezers market, and the trend is projected to continue during the forecast period.

Moreover, the COVID-19 outbreak is anticipated to drive the ultra-low temperature freezer market over the forecast period in the region owing to an increase in research and development activities for COVID-19 vaccines. For example, the BINDER CO2 freezer is helping scientists retain coronavirus samples during research.

Furthermore, the high adoption of technologically advanced ultra-low temperature freezers and product launches is expected to propel the growth of the overall regional market. For instance, in May 2020, Thermo Fisher Scientific launched a new service that collects and tracks crucial performance data from the linked TSX Series ULT freezers to ensure the safety of samples and products. Thermo Scientific's intelligent connected systems function keeps track of 37 types of alarms and 26 operating metrics, enabling the user to examine the linked TSX Series ULT freezers thoroughly.

Thus, all the factors mentioned above are expected to increase demand for ultra-low temperature freezers and boost market growth over the forecast period.

Ultra Low Temperature Freezers Market Competitor Analysis

The market studied is moderately competitive, and several companies are operating in this market. Some of the major players operating in the market include Thermo Fisher Scientific, Inc., PHC Holdings Corporation, Haier Biomedical, Arctiko A/S, Helmer Scientific, Eppendorf AG, Abzil Telstar S.L, Labcold Ltd., Bionics Scientific Technologies (P) Ltd., and Global Cooling, Inc., among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Applications in Bio-Banks, Drug Discovery and life-Sciences Research
    • 4.2.2 Technological Advancement in Ultra-Low Temperature Freezers
  • 4.3 Market Restraints
    • 4.3.1 High Costs Associated with Ultra-Low Temperature Freezers
    • 4.3.2 Stringent Regulatory Issues Regarding Ultra-Low Temperature Freezers
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Upright ULT freezers
    • 5.1.2 Chest ULT freezers
  • 5.2 By End User
    • 5.2.1 Bio-Banks
    • 5.2.2 Pharmaceutical and Biotechnology Companies
    • 5.2.3 Academic and Research Laboratories
    • 5.2.4 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific, Inc
    • 6.1.2 PHC Holdings Corporation
    • 6.1.3 Haier Biomedical
    • 6.1.4 Arctiko A/S
    • 6.1.5 Helmer Scientific
    • 6.1.6 Eppendorf AG
    • 6.1.7 Abzil Telstar S.L
    • 6.1.8 Labcold Ltd
    • 6.1.9 Bionics Scientific Technologies (P) Ltd
    • 6.1.10 Global Cooling, Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS